NCT05276661 is a NA clinical trial of TAC/Collagen gel in Skin Diseases, sponsored by Chia Nan University of Pharmacy ＆ Science.

Who is sponsoring NCT05276661?

NCT05276661 is sponsored by Chia Nan University of Pharmacy ＆ Science.

What drugs are being tested in NCT05276661?

Interventions in NCT05276661: TAC/Collagen gel, placebo lotion.

What condition does NCT05276661 study?

NCT05276661 studies Skin Diseases.

Is NCT05276661 still recruiting?

NCT05276661 is currently completed. Last updated 11 March 2022.

Last reviewed 2022-03-11 · How we verify

NCT05276661

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Project to Study Probiotic Beauty Products on Skin Improvement

Completed NA Last updated 11 March 2022

What this trial tests

NA trial testing TAC/Collagen gel in Skin Diseases in 20 participants. Completed in 15 August 2020.

Timeline

18 May 2020

Primary endpoint
1 August 2020

15 August 2020

Quick facts

Lead sponsor	Chia Nan University of Pharmacy ＆ Science
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	18 May 2020
Primary completion	1 August 2020
Estimated completion	15 August 2020
Sites	1 location across Taiwan

Drugs / interventions tested

TAC/Collagen gel
placebo lotion — full drug profile →

Conditions studied

Skin Diseases — all drugs for Skin Diseases →

Sponsor

Chia Nan University of Pharmacy ＆ Science

Who can join

Adults 20 to 65, any sex, with Skin Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to use probiotic beauty products for 4 weeks and evaluate the impact of products on healthy skin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Skin Diseases

Currently open trials in the same condition.

NCT07412691 — A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases · Phase 1 · recruiting
NCT07091604 — An Observational Study to Assess Objective Skin Pigmentation Variation. · recruiting
NCT07158879 — Skin Reactions Related to Thoracic Implantable Chamber Dressings · recruiting
NCT06850311 — Herbal Ointment in Treating Atopic Dermatitis Topically · Phase 2, PHASE3 · recruiting
NCT06563323 — Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Phase 2 · recruiting

Other Chia Nan University of Pharmacy ＆ Science trials

Trials by the same sponsor.

NCT06657352 — Skin Efficacy Testing of Astrion Products · NA · completed
NCT05872178 — Omegia Softgel Clinical Research Program · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05276661 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chia Nan University of Pharmacy ＆ Science
Last refreshed: 11 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05276661.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing